Located in Saint-Quentin-Lamotte, France, SGD Pharma's Type I Excellence Center combines advanced glass manufacturing, pharmaceutical packaging innovation and a strong commitment to more sustainable industrial operations.
With 270 skilled employees, an 11,000 m² manufacturing facility and an ISO 8 cleanroom, the site plays a key role in SGD Pharma's production of Type I molded glass vials.
One Million Type I Molded Glass Vials Every Day
The Saint-Quentin-Lamotte plant produces approximately one million Type I molded glass vials per day, supporting the pharmaceutical industry's need for high-quality primary glass packaging.
As SGD Pharma's flagship Type I manufacturing facility, the plant combines industrial expertise with continuous improvement and innovation.
SEALIAN: Advanced Internal Glass Treatment
Innovation is central to the activities of our Saint-Quentin-Lamotte Excellence Center.
The site has invested in SEALIAN, an internal glass treatment designed to protect sensitive pharmaceutical formulations through its barrier effect.
Its hydrophobic properties also support optimal product release, making the treatment particularly suitable for viscous solutions.
This technology illustrates how SGD Pharma combines glass manufacturing expertise with solutions developed to address specific pharmaceutical packaging challenges.
Reducing the Environmental Impact of Glass Manufacturing
The Saint-Quentin-Lamotte plant also contributes to SGD Pharma's decarbonization ambitions.
Our Group's Science Based Targets initiative (SBTi)-validated objectives include:
- 42% reduction in absolute Scope 1 and 2 emissions by 2030, compared with the 2022 baseline.
- 65% reduction in absolute Scope 1 and 2 emissions by 2040, compared with the same baseline.
To support these objectives, the facility features two furnaces using different technologies: a fully electric furnace and an oxy-gas combustion furnace with electric boosting.
These technologies contribute to reducing CO₂ emissions from glass production.
The plant also uses smart monitoring systems to track and reduce water consumption, supporting more efficient resource management.
Ten Years of Teamwork and Industrial Excellence
Beyond its manufacturing technologies and production capabilities, what makes Saint-Quentin-Lamotte exceptional is its people.
Over the past ten years, team spirit, dedication and a shared ambition have driven continuous improvement and breakthrough innovation.
From Type I molded glass vial production to SEALIAN technology and more energy-efficient manufacturing, SGD Pharma's Saint-Quentin-Lamotte Excellence Center demonstrates the value of combining industrial expertise, innovation and teamwork.